| Medical and Health Sciences | Lifetime | 189 | AU 9 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 164 | AU 7 | 99.97 |
| Complementary and Alternative Medicine | Lifetime | 3 | AU 1 | 99.96 |
| Cardiology and Cardiovascular Medicine | Lifetime | 37 | AU 2 | 99.97 |
| Medical Physiology | Lifetime | 603 | AU 21 | 98.97 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 13 | AU 1 | 99.93 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 248 | AU 8 | 94.92 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 510 | AU 22 | 94.36 |
| Cardiovascular and exercise physiology | Lifetime | 2 | AU 1 | 99.94 |
| Cardiovascular Function and Risk Factors | Lifetime | 14 | AU 2 | 99.96 |
| Heart Failure Treatment and Management | Lifetime | 10 | AU 1 | 99.94 |
| Heart Rate Variability and Autonomic Control | Lifetime | 17 | AU 3 | 99.84 |
| Cardiac pacing and defibrillation studies | Lifetime | 33 | AU 1 | 99.83 |
| Nutrition and Health in Aging | Lifetime | 72 | AU 2 | 99.57 |
| Blood Pressure and Hypertension Studies | Lifetime | 118 | AU 10 | 99.54 |
| Cardiovascular Effects of Exercise | Lifetime | 80 | AU 6 | 99.40 |
| GDF15 and Related Biomarkers | Lifetime | 23 | AU 4 | 98.14 |
| Cardiac Health and Mental Health | Lifetime | 164 | AU 7 | 98.54 |
| Diabetes Treatment and Management | Lifetime | 292 | AU 18 | 98.85 |
| Cardiac Structural Anomalies and Repair | Lifetime | 425 | AU 11 | 98.73 |
| Potassium and Related Disorders | Lifetime | 69 | AU 2 | 98.38 |
| Hemodynamic Monitoring and Therapy | Lifetime | 294 | AU 13 | 98.15 |
| Mechanical Circulatory Support Devices | Lifetime | 629 | AU 19 | 97.57 |
| Health and Medical Research Impacts | Lifetime | 232 | AU 10 | 94.90 |
| Non-Invasive Vital Sign Monitoring | Lifetime | 476 | AU 21 | 96.21 |
| Cardiac Fibrosis and Remodeling | Lifetime | 310 | AU 6 | 95.69 |
| Heart rate and cardiovascular health | Lifetime | 73 | AU 3 | 95.11 |
| Frailty in Older Adults | Lifetime | 994 | AU 60 | 94.26 |
| Erythropoietin and Anemia Treatment | Lifetime | 774 | AU 26 | 90.38 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 925 | AU 27 | 87.27 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 4 | AU 1 | 99.86 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 15 | AU 1 | 99.88 |
| Heart Failure Treatment and Management | 2021-2025 | 16 | AU 1 | 99.87 |
| Diabetes Treatment and Management | 2021-2025 | 126 | AU 4 | 98.61 |
| Potassium and Related Disorders | 2021-2025 | 16 | AU 1 | 98.18 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 171 | AU 2 | 97.58 |
| Nutrition and Health in Aging | 2021-2025 | 463 | AU 26 | 95.06 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 671 | AU 27 | 89.45 |
| Cardiovascular and exercise physiology | 2021-2025 | 476 | AU 32 | 91.40 |
| Cardiac Health and Mental Health | 2021-2025 | 472 | AU 30 | 88.33 |
| Electrolyte and hormonal disorders | 2021-2025 | 355 | AU 15 | 77.80 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 362 | AU 12 | 72.71 |
| GDF15 and Related Biomarkers | 2021-2025 | 419 | AU 7 | 62.17 |
